HT2 INFLUENCE OF HTA AND HOSPITAL FUNDING SYSTEMS ON PATIENT ACCESS TO INNOVATIVE MEDICINES- EXAMPLE OF ADVANCED RENAL CELL CANCER IN WESTERN EUROPE
Abstract
Authors
M Toumi J Misset S Jaroslawski S Aballea E Baynton M Lamure
M Toumi J Misset S Jaroslawski S Aballea E Baynton M Lamure
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now